Skip to Main Content

Paper Details

Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs.
Am Heart J
5
2022
Author NameAffiliation
Mahmoud Al RifaiBaylor College of Medicine
Dhruv MahttaBaylor College of Medicine, Michael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality
David J RamseyMichael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality
Michelle T LeeBaylor College of Medicine, Michael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality
Chayakrit KrittanawongBaylor College of Medicine
Sankar D NavaneethanSection of Nephrology and Institute of Clinical and Translational Research, Baylor College of Medicine, and Michael E. DeBakey VA Medical Center
Lucile Parker GreggBaylor College of Medicine
Laura A PetersenBaylor College of Medicine, TX Section of Health Services Research
Salim S ViraniBaylor College of Medicine, Michael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality, Michael E. DeBakey Veterans Affairs Medical Center
  • 1 - 9

Datasets